SCHEMBL1076574

SCHEMBL1076574

CCCC(CC)(C(=O)O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ HDAC1 Q13547 1/20 0.44
▸ CYP2C19 P33261 4/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ DRD2 P14416 1/20 0.41
▸ OPRM1 P35372 1/20 0.41
▸ DRD3 P35462 1/20 0.41
▸ CYP1A2 P05177 4/20 0.41
▸ LMNA P02545 3/20 0.41
▸ SCN1A P35498 3/20 0.41
▸ SCN2A Q99250 3/20 0.41
▸ SCN3A Q9NY46 3/20 0.41
▸ CYP2D6 P10635 3/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ KIF11 P52732 2/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ MTOR P42345 1/20 0.41
▸ RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4002970 0.92 TSHR (0.53) TSHRALDH1A1HDAC1CYP2C19HIF1A
SCHEMBL8905858 0.91 ALDH1A1 (0.49) TSHRALDH1A1HDAC1CYP2C19HIF1A
SCHEMBL8904807 0.89 TSHR (0.47) TSHRALDH1A1HDAC1CYP2C19HIF1A
SCHEMBL504013 0.88 ALDH1A1 (0.57) TSHRALDH1A1HDAC1CYP2C19HIF1A
SCHEMBL8905848 0.87 ALDH1A1 (0.46) TSHRALDH1A1HDAC1KIF11GAA
SCHEMBL8903837 0.87 ALDH1A1 (0.46) TSHRALDH1A1HDAC1KIF11GAA
SCHEMBL8905573 0.87 ALDH1A1 (0.46) TSHRALDH1A1HDAC1KIF11GAA
SCHEMBL8905259 0.87 ALDH1A1 (0.46) TSHRALDH1A1HDAC1KIF11GAA
SCHEMBL6761557 0.87 TSHR (0.49) TSHRALDH1A1HDAC1CYP2C19HIF1A
SCHEMBL1131428 0.87 ALDH1A1 (0.49) TSHRALDH1A1CYP2C19HIF1ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8389466-B2 Use of carboxylic acid esters as a fragrance substance SYMRISE AG (DE) 2013-03-05 — — US disclosed
EP-2274409-B1 USE OF CARBOXYLIC ACID ESTERS AS A FRAGRANCE SUBSTANCE SYMRISE AG (DE) 2011-10-12 — — EP disclosed
US-20110104092-A1 USE OF CARBOXYLIC ACID ESTERS AS A FRAGRANCE SUBSTANCE SYMRISE AG (DE) 2011-05-05 — — US disclosed
EP-2274409-A1 USE OF CARBOXYLIC ACID ESTERS AS A FRAGRANCE SUBSTANCE Symrise AG (DE) 2011-01-19 — — EP disclosed
US-20100158905-A1 COMBINATION THERAPY OF ARTHRITIS WITH TRANILAST NUON THERAPEUTICS, INC. (US) 2010-06-24 — — US disclosed
EP-1920042-B1 PARTICLES CONTAINING PERFUME HAVING IMPROVED FRAGRANCED PROPERTIES HENKEL AG & CO KGAA (DE) 2010-06-23 — — EP disclosed
WO-2009124888-A1 USE OF CARBOXYLIC ACID ESTERS AS A FRAGRANCE SUBSTANCE SYMRISE GMBH & CO. KG (DE) 2009-10-15 — — WO disclosed
US-5597848-A PLATELET AGGREGATION INHIBITORS, ANTITHROMBOTIC AGENTS, ANTIASTHMATIC AGENTS, ANTIALLERGIC AGENTS HOKURIKU SEIYAKU CO., LTD. (JP) 1997-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100158905-A1 COMBINATION THERAPY OF ARTHRITIS WITH TRANILAST PTGS2, PTGES2, PTGES TSHR 2986/4885ALDH1A1 351/4885HDAC1 638/4885
US-20110104092-A1 USE OF CARBOXYLIC ACID ESTERS AS A FRAGRANCE SUBSTANCE FASN, ELOVL5, ALDH16A1 TSHR 4478/4885ALDH1A1 9/4885HDAC1 1393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback